In the last couple of years, a lot has been learned about the power of leveraging epigenetics to generate diagnostic, prognostic, and predictive signatures, specifically in methylation, explained Kathleen C. Barnes, professor of medicine and epidemiology at the University of Colorado Anschutz Medical Campus.